Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-05

Clinical Trial Update: Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting on the efficacy and safety of TV-1380 as a treatment to facilitate abstinence in cocaine use disorder, with the study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TV-1380 (TV-1380)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Cocaine Addiction | Phase 2 | Status: COMPLETED